| 000 | 01132 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517102040.0 | ||
| 264 | 0 | _c20170112 | |
| 008 | 201701s 0 0 eng d | ||
| 022 | _a1879-0461 | ||
| 024 | 7 |
_a10.1016/j.critrevonc.2016.04.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAgarwal, Amit B | |
| 245 | 0 | 0 |
_aUnderstanding the biosimilar approval and extrapolation process-A case study of an epoetin biosimilar. _h[electronic resource] |
| 260 |
_bCritical reviews in oncology/hematology _cAug 2016 |
||
| 300 |
_a98-107 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiosimilar Pharmaceuticals _xpharmacology |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aErythropoietin _xpharmacology |
| 650 | 0 | 4 | _aEuropean Union |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aMcBride, Ali | |
| 773 | 0 |
_tCritical reviews in oncology/hematology _gvol. 104 _gp. 98-107 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.critrevonc.2016.04.016 _zAvailable from publisher's website |
| 999 |
_c26137534 _d26137534 |
||